Vaginal Cancer Clinical Trials

Vaginal cancer clinical trials represent a crucial step in making new treatments available for widespread use. Once a promising new treatment has been identified and developed, it is then compared to the current standard of care. Clinical trials allow researchers to determine if a new therapy is more effective than the current option, or if it can produce comparable outcomes with fewer side effects.

  • Which imaging techniques can help determine if lymph nodes should be removed
  • Whether stem cell transplants are beneficial in the treatment of recurrent vaginal cancer
  • How nutritional supplements can help counteract the side effects of chemotherapy
  • Which chemotherapy drugs and combinations of drugs are most effective for late-stage cancers

Other trials have focused on developing more effective ways to use existing treatments. For instance, one previous trial studied the outcomes of patients with specific DNA mutations who received external beam radiation therapy as part of their treatment. Now, oncologists can use the information gathered during this study to create more effective radiation therapy plans for patients who possess these unique genetic characteristics.

At Moffitt Cancer Center, we have been nationally recognized for our commitment to translational research. Many of the breakthroughs we’ve achieved in our labs have been fast-tracked into exciting new treatments; as a result, we’ve been named a Comprehensive Cancer Center by the National Cancer Institute. With more than 400 clinical trials in progress at any given time, we offer an abundance of opportunities for patients who wish to participate in and benefit from groundbreaking research. 

To learn more about our vaginal cancer clinical trials, call 1-888-663-3488 or submit a new patient registration form online. Clinical trial participation does not require a physician referral.